Hinge Health (HNGE) EBIT (2024 - 2026)

Hinge Health has disclosed EBIT across 3 years of filings, most recently posting $40.4 million for Q2 2026.

• In Q2 2026, EBIT rose 106.96% year-over-year to $40.4 million; the TTM figure through Jun 2026 stood at $93.7 million (up 117.02% YoY), while the FY2025 annual figure was -$546.4 million, down 1612.23% from the prior year.
• EBIT came in at $40.4 million for Q2 2026 at Hinge Health, up from $32.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $40.4 million in Q2 2026 to a low of -$580.7 million in Q2 2025.
• Average EBIT over 3 years is -$52.7 million, with a median of $13.1 million recorded in 2025.
• Year-over-year, EBIT sank 3208.48% in 2025 and jumped 144.11% in 2026.
• Over 3 years, EBIT stood at $20.9 million in 2024, then soared by 30.35% to $27.3 million in 2025, then surged by 48.37% to $40.4 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were $40.4 million in Q2 2026, $32.1 million in Q1 2026, and $27.3 million in Q4 2025.